会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Pyridinone Diketo Acids: Inhibitors of HIV Replication in Combination Therapy
    • 吡啶酮二酮酸:联合治疗HIV复制抑制剂
    • US20100092427A1
    • 2010-04-15
    • US12309017
    • 2007-07-13
    • Vasu NairByung I. SeoVinod R. UchilGuochen Chi
    • Vasu NairByung I. SeoVinod R. UchilGuochen Chi
    • A61K31/4412C07D213/64A61K38/21A61K39/395A61P31/18
    • C07D213/64C07D213/68
    • A new class of diketo acids constructed on pyridinone scaffolds, designed as inhibitors of HTV replication through inhibition of HIV integrase, is described. These compounds are useful in the prevention or treatment of infection by HIV and in the treatment of AIDS and ARC, either as the compounds, or as pharmaceutically acceptable salts, with pharmaceutically acceptable carriers, used alone or in combination with antivirals, immunomodulators, antibiotics, vaccines, and other therapeutic agents, especially other anti-HIV compounds (including other anti-HIV integrase agents), which can be used to create combination anti-HIV cocktails. Methods of treating AIDS and ARC and methods of treating or preventing infection by HIV are also described. Compounds of the present application include those of formula I and include tautomers, regioisomers, geometric isomers, and pharmaceutically acceptable salts thereof, wherein the pyridinone scaffold and R groups are as otherwise defined in the specification. These are combined, with any number of typical other anti-HIV agents (including other integrase-based anti-HIV agents) and other combination therapeutic agents described herein, to provide an effective treatment modality for HIV infections, including AIDS and ARC.
    • 描述了在吡啶酮支架上构建的一类新的二酮酸,其通过抑制HIV整合酶设计为HTV复制的抑制剂。 这些化合物可用于预防或治疗艾滋病毒感染和治疗AIDS和ARC,作为化合物或作为药学上可接受的盐与药学上可接受的载体,单独使用或与抗病毒剂,免疫调节剂,抗生素联合使用, 疫苗和其他治疗剂,特别是可用于产生组合抗HIV鸡尾酒的其它抗HIV化合物(包括其它抗HIV整合酶试剂)。 还描述了治疗AIDS和ARC的方法以及治疗或预防HIV感染的方法。 本申请的化合物包括式I的化合物,并且包括互变异构体,区域异构体,几何异构体及其药学上可接受的盐,其中吡啶酮支架和R基团如本说明书另有定义。 将这些与任何数量的典型的其它抗HIV剂(包括其它基于整合酶的抗HIV剂)和本文所述的其它组合治疗剂组合起来,为HIV感染(包括AIDS和ARC)提供有效的治疗方式。
    • 5. 发明授权
    • Pyridinone diketo acids: inhibitors of HIV replication
    • 吡啶酮二酮酸:HIV复制抑制剂
    • US07888375B2
    • 2011-02-15
    • US11827959
    • 2007-07-13
    • Vasu NairByung I. SeoVinod R. Uchil
    • Vasu NairByung I. SeoVinod R. Uchil
    • A61K31/44C07D211/86
    • C07D213/64C07D213/68
    • A new class of diketo acids constructed on pyridinone scaffolds, designed as inhibitors of HIV replication through inhibition of HIV integrase, is described. These compounds are useful in the prevention or treatment of infection by HIV and in the treatment of AIDS and ARC, either as the compounds, or as pharmaceutically acceptable salts, with pharmaceutically acceptable carriers, used alone or in combination with antivirals, immunomodulators, antibiotics, vaccines, and other therapeutic agents, especially other anti-HIV compounds (including other integrase-based anti-HIV agents). Methods of treating AIDS and ARC and methods of treating or preventing infection by HIV are also described.
    • 描述了在吡啶酮支架上构建的一类新的二酮酸,其通过抑制HIV整合酶被设计为HIV复制的抑制剂。 这些化合物可用于预防或治疗艾滋病毒感染和治疗AIDS和ARC,作为化合物或作为药学上可接受的盐与药学上可接受的载体,单独使用或与抗病毒剂,免疫调节剂,抗生素联合使用, 疫苗和其他治疗剂,特别是其它抗HIV化合物(包括其它基于整合酶的抗HIV药物)。 还描述了治疗AIDS和ARC的方法以及治疗或预防HIV感染的方法。